Arbutus Biopharma Corporation Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Arbutus Biopharma Corporation stock price up 0.368% on Friday
(Updated on Apr 26, 2024)
The Arbutus Biopharma Corporation stock price gained 0.368% on the last trading day (Friday, 26th Apr 2024), rising from $2.72 to $2.73. During the last trading day the stock fluctuated 2.21% from a day low at $2.71 to a day high of $2.77. The price has fallen in 6 of the last 10 days and is down by -6.19% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 83 thousand more shares were traded than the day before. In total, 401 thousand shares were bought and sold for approximately $1.09 million.
The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 6.75% during the next 3 months and, with a 90% probability hold a price between $2.72 and $3.38 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
ABUS Signals & Forecast
There are mixed signals in the stock today. The Arbutus Biopharma Corporation stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $2.73. On a fall, the stock will find some support from the short-term average at $2.72. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, April 05, 2024, and so far it has fallen -12.50%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Arbutus Biopharma Corporation has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.
Support, Risk & Stop-loss for Arbutus Biopharma Corporation stock
Arbutus Biopharma Corporation finds support from accumulated volume at $2.72 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0600 between high and low, or 2.21%. For the last week, the stock has had daily average volatility of 2.89%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ABUS) For The Upcoming Trading Day Of Monday 29th
For the upcoming trading day on Monday, 29th we expect Arbutus Biopharma Corporation to open at $2.74, and during the day (based on 14 day Average True Range), to move between $2.60 and $2.86, which gives a possible trading interval of +/-$0.125 (+/-4.58%) up or down from last closing price. If Arbutus Biopharma Corporation takes out the full calculated possible swing range there will be an estimated 9.16% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $2.72 (0.37%) than the resistance at $2.92 (6.96%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Arbutus Biopharma Corporation will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.100. We will update the financials statements for Arbutus Biopharma Corporation, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 8.58% in the first trading day after earnings release.
Is Arbutus Biopharma Corporation stock A Buy?
Arbutus Biopharma Corporation holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -1.789 Sell Candidate Unchanged
Predicted Opening Price for Arbutus Biopharma Corporation of Monday, April 29, 2024
| Fair opening price April 29, 2024 | Current price |
|---|---|
| $2.74 ( 0.244%) | $2.73 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ABUS
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.80 | 2.44 % | |
| R2 | 2.77 | 1.60 % | ||
| R1 | 2.76 | 1.08 % | ||
| Current price: | 2.73 | |||
| Support | S1 | 2.71 | -0.595 % | |
| S2 | 2.70 | -1.11 % | ||
| S3 | 2.68 | -1.95 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 3.12 | 14.29 % | |
| R2 | 3.00 | 9.89 % | ||
| R1 | 2.92 | 6.96 % | ||
| Current price | 2.73 | |||
| Support | S1 | 2.72 | -0.366% | |
| S2 | 2.54 | -6.96% | ||
| S3 | 2.49 | -8.79% |
FAQ
Click here for our free guide on how to buy Arbutus Biopharma Corporation Stock.
